Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NRC HealthNRC -0.98%63 EV-to-EBITDA is 23.72 as of Aug. 15, 2026, which is 11% above its 10-year median of 21.32. GuruFocus rates NRC with a GF Score™ of 63/100 and a GF Value™ of $19.94 (Fairly Valued). The stock has 8 warning signs investors should review. Among 511 Healthcare Providers & Services companies, NRC Health ranks worse than 81.21% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, NRC Health's enterprise value is $555.5 Mil.
NRC Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was $23.4 Mil. Therefore, NRC Health's EV-to-EBITDA for today is 23.72.
The historical rank and industry rank for NRC Health's EV-to-EBITDA or its related term are showing as below:
NRC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.39 Med: 21.32 Max: 37.76
Current: 23.72
During the past 13 years, the highest EV-to-EBITDA of NRC Health was 37.76. The lowest was 7.39. And the median was 21.32.
NRC's EV-to-EBITDA is ranked worse than 81.21% of 511
companies
in the Healthcare Providers & Services industry
Industry Median: 10.76
vs NRC: 23.72
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
NRC Health's share price for today is $21.195.
NRC Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.250.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for NRC Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, NRC Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NRC Health EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NRC Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where NRC Health's EV-to-EBITDA falls into.
NRC Health's current Enterprise Value is $555.5 Mil.
NRC Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $23.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NRC Health (NRC) has a EV-to-EBITDA of 23.72 as of Aug. 15, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on NRC Health. This is 11% above median its historical median of 21.32. Over the past decade, NRC Health's EV-to-EBITDA has ranged from 7.39 to 37.76. According to the industry distribution chart, NRC Health ranks #415 out of 511 companies in the Healthcare Providers & Services industry, placing it in the top 81.2%.
Is NRC Health's EV-to-EBITDA too high?
NRC Health's current EV-to-EBITDA of 23.72 is 11% above median its 10-year median of 21.32. Over the past 10 years, this metric has ranged from a low of 7.39 to a high of 37.76. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.76. NRC Health's value of 23.72 is 120.4% above this industry median. Based on the distribution chart, NRC Health ranks #415 out of 511 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, NRC Health has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does NRC Health's EV-to-EBITDA compare to EVH and SOPH?
According to the Healthcare Providers & Services industry distribution chart, NRC Health ranks #415 out of 511 companies for EV-to-EBITDA. This places NRC Health in the lower half of its industry. The industry median EV-to-EBITDA is 10.76. NRC Health's value of 23.72 is 120.4% above this benchmark. Historically, NRC Health's own EV-to-EBITDA has ranged from 7.39 to 37.76 over the past decade. While the company's 10-year median is 21.32 vs. the industry median of 10.76, NRC Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.76, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NRC Health's current EV-to-EBITDA of 23.72 is 120.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on NRC Health. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NRC Health's current EV-to-EBITDA is 23.72, which is 11% above median its own 10-year median of 21.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NRC Health stock overvalued right now?
Based on GuruFocus' analysis, NRC Health (NRC) is currently considered Fairly Valued. The stock's GF Value™ is $19.94, compared to a current price of $21.20 — trading 6.3% above its estimated fair value. The current EV-to-EBITDA is 23.72, which is 11% above median its 10-year median of 21.32 and 120.4% above the Healthcare Providers & Services industry median of 10.76. NRC Health's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For NRC Health (NRC), the current EV-to-EBITDA is 23.72 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NRC Health (NRC) Overvalued in 2026?
Based on GuruFocus' analysis, NRC Health stock appears to be overvalued.
The current stock price of $21.20 is trading 6.3% above its estimated GF Value™ of $19.94.
GuruFocus considers NRC Health to be Fairly Valued.
Key valuation signals for NRC:
EV-to-EBITDA: 23.72 (11% above median its 10-year median of 21.32)
GF Value™: $19.94 vs. price of $21.20 (6.3% above fair value)
Industry Position: 120.4% above the Healthcare Providers & Services median (#415 of 511)
No single metric tells the full story. See the NRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.
63GF Score
Get the complete analysis for NRC
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NRC has been successfully added to your 
